Walleye Capital’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-74,375
| Closed | -$67.7K | – | 2074 |
|
|
2025
Q1 | $67.7K | Sell |
74,375
-163,245
| -69% | -$149K | ﹤0.01% | 1595 |
|
|
2024
Q4 | $658K | Buy |
+237,620
| New | +$658K | ﹤0.01% | 1068 |
|
|
2023
Q4 | – | Sell |
-35,058
| Closed | -$147K | – | 2553 |
|
|
2023
Q3 | $147K | Sell |
35,058
-206,013
| -85% | -$865K | ﹤0.01% | 1573 |
|
|
2023
Q2 | $1.34M | Buy |
+241,071
| New | +$1.34M | ﹤0.01% | 638 |
|
|
2022
Q4 | – | Sell |
-117,529
| Closed | -$315K | – | 2365 |
|
|
2022
Q3 | $315K | Buy |
117,529
+16,087
| +16% | +$43.1K | 0.01% | 1272 |
|
|
2022
Q2 | $484K | Buy |
+101,442
| New | +$484K | 0.01% | 1028 |
|
|
2022
Q1 | – | Sell |
-15,588
| Closed | -$106K | – | 2353 |
|
|
2021
Q4 | $106K | Buy |
+15,588
| New | +$106K | ﹤0.01% | 1614 |
|